Ocular toxoplasmosis.
D000022:Abortion, Spontaneous / Q000209:etiology; D000328:Adult; D000818:Animals; D003937:Diagnosis, Differential; D005128:Eye Diseases / Q000175:diagnosis; D005260:Female; D006801:Humans; D006967:Hypersensitivity; D007231:Infant, Newborn; D007249:Inflammation; D002955:Leucovorin / Q000627:therapeutic use; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D011739:Pyrimethamine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D013587:Syphilis / Q000175:diagnosis; D014122:Toxoplasma / Q000166:cytology / Q000254:growth & development / Q000302:isolation & purification; D014123:Toxoplasmosis / Q000150:complications / Q000473:pathology; D014125:Toxoplasmosis, Congenital; D014126:Toxoplasmosis, Ocular / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D014376:Tuberculosis / Q000175:diagnosis
D013411:Sulfadiazine; D002955:Leucovorin; D011241:Prednisone; D011739:Pyrimethamine